Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic
- PMID: 24791022
- PMCID: PMC3982543
- DOI: 10.1177/003335491412900306
Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic
Abstract
Objective: Infants are at greatest risk for mortality from pertussis infection. Since 2005, the Advisory Committee on Immunization Practices has recommended a cocooning strategy of vaccinating all close contacts of infants with tetanus, diptheria, and acellular pertussis (Tdap) vaccine to reduce the risk of transmitting pertussis. Difficulties in establishing a complete cocoon have been reported in the literature. We determined whether families of newborns could be fully immunized against pertussis, thereby providing a complete cocoon of protection.
Methods: Tdap vaccine was offered during visiting hours to contacts aged 7 years and older and to postpartum patients who had not received Tdap vaccine during pregnancy. We then conducted retrospective phone interviews with randomly selected mothers (or other family members) to assess vaccination rates. We compared household vaccination rates during intervention and control periods and the demographic factors associated with Tdap vaccination of all members within the households.
Results: During the intervention period, 243 postpartum patients and 1,287 other family members of newborns were immunized, with 84.8% of all family members receiving Tdap vaccination. Seventy-six percent of households reported a complete cocoon. In the control group, 52.2% of all family members received Tdap vaccination, and 29.3% of households had a complete cocoon. In the control group, fewer family members completed Tdap vaccination in the larger households than in the smaller households (p=0.008).
Conclusion: A cocooning strategy can be successfully implemented, such that the majority of newborns leave the hospital with their families fully immunized against pertussis.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3982543/bin/7_RosenblumFigure1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3982543/bin/7_RosenblumFigure2.gif)
Similar articles
-
Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.Pediatrics. 2013 Jun;131(6):e1748-56. doi: 10.1542/peds.2012-3144. Epub 2013 May 27. Pediatrics. 2013. PMID: 23713104
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.MMWR Morb Mortal Wkly Rep. 2011 Oct 21;60(41):1424-6. MMWR Morb Mortal Wkly Rep. 2011. PMID: 22012116
-
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37. MMWR Recomm Rep. 2006. PMID: 17167397
-
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.Public Health. 2020 Feb;179:38-44. doi: 10.1016/j.puhe.2019.10.001. Epub 2019 Nov 11. Public Health. 2020. PMID: 31726399 Review.
Cited by
-
Factors Affecting the Implementation and Acceptance of the Cocoon Strategy in the NICU in a Tertiary Center in Türkiye.Vaccines (Basel). 2024 Mar 18;12(3):319. doi: 10.3390/vaccines12030319. Vaccines (Basel). 2024. PMID: 38543953 Free PMC article.
-
Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic.Front Public Health. 2022 Aug 4;10:903557. doi: 10.3389/fpubh.2022.903557. eCollection 2022. Front Public Health. 2022. PMID: 35991061 Free PMC article.
-
Strategies to increase uptake of maternal pertussis vaccination.Expert Rev Vaccines. 2021 Jul;20(7):779-796. doi: 10.1080/14760584.2021.1940146. Epub 2021 Jul 21. Expert Rev Vaccines. 2021. PMID: 34129416 Free PMC article.
-
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2018 Apr 27;67(2):1-44. doi: 10.15585/mmwr.rr6702a1. MMWR Recomm Rep. 2018. PMID: 29702631 Free PMC article.
-
An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.Clin Infect Dis. 2016 Dec 1;63(suppl 4):S221-S226. doi: 10.1093/cid/ciw528. Clin Infect Dis. 2016. PMID: 27838676 Free PMC article.
References
-
- Summary of notifiable diseases—United States, 2010 [published erratum appears in MMWR Morb Mortal Wkly Rep 2012;61 (29):562] MMWR Morb Mortal Wkly Rep. 2012;59(53):1–111. - PubMed
-
- Winter K, Harriman K, Zipprich J, Schecter R, Talarico J, Watt J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;161:1091–6. - PubMed
-
- Pertussis epidemic—Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(28):517–22. - PubMed
-
- Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003;22:628–34. - PubMed
-
- Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008;121:484–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical